Targeting protein–protein interactions by rational design: mimicry of protein surfaces
- 8 March 2006
- journal article
- review article
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 3 (7) , 215-233
- https://doi.org/10.1098/rsif.2006.0115
Abstract
Protein-protein interactions play key roles in a range of biological processes, and are therefore important targets for the design of novel therapeutics. Unlike in the design of enzyme active site inhibitors, the disruption of protein-protein interactions is far more challenging, due to such factors as the large interfacial areas involved and the relatively flat and featureless topologies of these surfaces. Nevertheless, in spite of such challenges, there has been considerable progress in recent years. In this review, we discuss this progress in the context of mimicry of protein surfaces: targeting protein-protein interactions by rational design.Keywords
This publication has 108 references indexed in Scilit:
- Terphenyl‐Based Helical Mimetics That Disrupt the p53/HDM2 InteractionAngewandte Chemie International Edition in English, 2005
- Binding Mode and Transcriptional Activation Potential of High Affinity Ligands for the CBP KIX DomainJournal of the American Chemical Society, 2005
- Light-induced inhibition of chymotrypsin using photocleavable monolayers on gold nanoparticlesChemical Communications, 2004
- Catalytic Unfolding and Proteolysis of Cytochrome c Induced by Synthetic Binding AgentsJournal of the American Chemical Society, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Development of a Potent Bcl-xLAntagonist Based on α-Helix MimicryJournal of the American Chemical Society, 2002
- Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell linesOncogene, 2002
- Binding of Soluble Recombinant HIV Envelope Glycoprotein, rgp120, Induces Conformational Changes in the Cellular Membrane-Anchored CD4 MoleculeBiochemical and Biophysical Research Communications, 1999
- Adhesion Molecules as Targets for the Treatment of Autoimmune DiseasesClinical Immunology and Immunopathology, 1996
- Cysteine pairing in the glycoprotien IIbIIIa antagonist kistrin using NMR, chemical analysis, and structure calculationsBiochemistry, 1993